Apollo Hospitals logo

Apollo Hospitals

APOLLOHOSP NSE

Key Fundamentals

LargecapHospitalsHealthcare Services
Market Cap
1.3L Cr
Volatility
Moderate
P/E Ratio
60.8
EBITDA
₹3,961 Cr
Return on Equity
20.08%
Debt to Equity
0.9
Book Value
₹659.33
EPS
₹72.05
52W High
₹9,050
52W Low
₹6,696.5

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has delivered good profit growth of 76.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.7%

Weaknesses

2
  • Stock is trading at 13.4 times its book value
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
15.58% higher than 3Y
Net Income Growth
33.06% higher than 3Y
Cash Flow Change
33.67% lower than 3Y
ROE
15.47% lower than 3Y
ROCE
27.43% lower than 3Y
EBITDA Margin (Avg.)
6.35% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk medium

Apollo Hospitals Enterprise Ltd commands a market cap of ₹1,26,883 Cr with a PE of 58.8x and a 5-year profit CAGR of 76%. ROE has improved to 21% in the last year from a 10-year average of 13%, while the stock trades at 13.5x book value with TTM sales growth of 17%.

Bull Case 7
  • Exceptional 5-year compounded profit growth of 76% CAGR, indicating a sharp improvement in profitability and operating leverage
  • ROE has expanded from a 10-year average of 13% to 21% in the last year, reflecting improving capital efficiency
  • TTM revenue growth of 17% with a 10-year sales CAGR of 15%, demonstrating consistent top-line expansion across cycles
  • 3-year stock CAGR of 21% has outperformed broader market indices, reflecting sustained investor confidence
  • TTM profit growth of 34% is more than double the TTM sales growth of 17%, suggesting margin expansion and better cost management
  • Consistent dividend payout ratio of 17.7% provides a degree of capital return discipline despite being in a growth phase
  • 3-year compounded profit growth of 32% is well ahead of the 3-year sales CAGR of 15%, pointing to durable operating leverage
Bear Case 7
  • PE ratio of 58.8x is significantly elevated compared to broader market averages, leaving limited margin of safety if growth slows
  • Price-to-book ratio of 13.5x is very high, meaning the stock prices in substantial future value creation beyond current assets
  • Dividend yield of just 0.22% offers negligible income return for shareholders at current price levels
  • Potential capitalisation of interest costs could be flattering reported profitability and understating true operating expenses
  • 5-year stock CAGR of 14% lags the 5-year profit CAGR of 76%, suggesting much of the profit recovery was from a low base rather than sustainable uplift
  • 10-year profit CAGR of 23% is materially lower than the 5-year figure of 76%, indicating recent growth rates may not be sustainable over longer horizons
  • At ₹1,26,883 Cr market cap, the company needs to sustain high-teens revenue growth and expanding margins to justify current valuation multiples

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Positives 1
  • AGM clears ₹7,500 cr debt limit Aug 25

    Shareholders approved all eight resolutions at the 45th AGM on August 25, including a ₹7,500 crore NCD issuance limit and reappointment of Dr. Prathap C Reddy as Executive Chairman, signaling governance continuity and financial flexibility.

Neutral 1
  • Revised FY26 annual report filed Aug 28

    Apollo Hospitals submitted a corrected annual report on August 28 to fix an editorial paragraph omission from the original filing on August 1, 2026. No material changes reported.

TL;DR: Apollo Hospitals shows steady governance with a smooth AGM and board continuity under Dr. Prathap C Reddy. The approved ₹7,500 crore NCD limit provides headroom for future expansion or refinancing. No material headwinds emerged in the recent news cycle. The outlook remains stable, with the debt facility approval positioning the company for potential capital deployment ahead.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4,418
4,847
4,851
4,944
5,086
5,589
5,527
5,592
5,842
6,304
6,477
6,606
7,044
Expenses
3,909
4,219
4,237
4,303
4,410
4,774
4,765
4,822
4,990
5,362
5,512
5,594
5,951
Operating Profit
509
628
614
640
675
816
762
770
852
941
965
1,011
1,092
OPM %
12%
13%
13%
13%
13%
15%
14%
14%
15%
15%
15%
15%
16%
Other Income
34
26
29
37
49
44
69
72
54
61
48
54
62
Interest
106
111
113
119
116
118
110
115
108
110
113
119
120
Depreciation
167
163
167
190
177
184
185
211
215
218
219
224
235
PBT
270
379
363
368
430
557
536
516
583
675
682
722
799
Tax %
36%
34%
30%
30%
27%
29%
29%
20%
24%
27%
24%
24%
24%
Net Profit
173
249
254
258
316
396
379
414
441
494
516
551
610
EPS in Rs
11.59
16.2
17.06
17.65
21.23
26.34
25.89
27.1
30.1
33.19
34.93
36.81
40.39
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5,129
6,150
7,256
8,243
9,617
11,247
10,560
14,663
16,612
19,059
21,794
25,228
26,430
Expenses
4,392
5,465
6,522
7,442
8,548
9,656
9,420
12,474
14,548
16,665
18,761
21,449
22,420
Operating Profit
737
684
734
801
1,070
1,591
1,140
2,189
2,065
2,394
3,033
3,779
4,010
OPM %
14%
11%
10%
10%
11%
14%
11%
15%
12%
13%
14%
15%
15%
Other Income
47
92
60
24
26
222
103
368
75
123
222
207
226
Interest
118
180
257
295
327
533
449
379
381
449
458
450
462
Depreciation
212
264
314
359
396
620
573
601
615
687
758
876
896
PBT
455
332
222
171
373
660
221
1,578
1,144
1,380
2,039
2,661
2,877
Tax %
29%
29%
41%
65%
47%
34%
38%
30%
22%
32%
26%
25%
—
Net Profit
335
235
131
60
200
432
137
1,108
844
935
1,505
2,003
2,172
EPS in Rs
24.43
16.99
15.88
8.44
16.96
32.7
10.46
73.42
56.97
62.5
101
135
145
Div. Payout %
24%
35%
38%
59%
35%
18%
29%
16%
26%
26%
13%
15%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
70
70
70
70
70
70
72
72
72
72
72
72
Reserves
3,102
3,262
3,244
3,182
3,264
3,270
4,531
5,551
6,126
6,864
8,140
9,408
Borrowings
1,992
2,834
3,125
3,427
3,673
3,596
4,160
4,068
4,332
5,333
7,864
8,493
Other Liabilities
1,296
1,195
1,665
1,917
2,159
4,354
2,629
3,570
3,886
4,474
4,568
4,210
Total Liabilities
6,459
7,360
8,103
8,596
9,166
11,289
11,392
13,261
14,416
16,742
20,644
22,183
Fixed Assets
3,244
3,997
4,591
4,773
4,982
7,432
6,778
8,296
8,520
9,664
10,988
12,272
CWIP
533
562
347
712
822
236
234
46
610
873
921
1,032
Investments
311
352
406
352
462
434
1,343
816
574
986
2,487
2,179
Other Assets
2,372
2,448
2,759
2,759
2,901
3,187
3,037
4,104
4,712
5,219
6,248
6,700
Total Assets
6,459
7,360
8,103
8,596
9,166
11,289
11,392
13,261
14,416
16,742
20,644
22,183
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
470
597
623
537
905
1,293
1,265
1,696
1,377
1,920
2,136
2,856
Investing
-759
-888
-1,152
-405
-711
-289
-880
-747
-857
-1,537
-3,383
-2,145
Financing
392
330
477
-108
-215
-910
-340
-792
-633
-311
1,319
-478
Net Cash Flow
103
39
-52
24
-20
94
44
158
-113
72
73
233
Free Cash Flow
-396
-393
-46
-84
233
782
984
1,044
252
785
439
925
CFO/OP
77
108
103
83
103
100
108
87
85
100
86
92
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
43
36
38
37
39
33
46
44
49
48
51
50
Inventory Days
50
49
47
51
46
49
16
21
17
17
16
15
Days Payable
59
66
51
55
56
60
74
79
82
88
72
63
Cash Conversion Cycle
34
19
34
33
29
22
-12
-14
-16
-23
-6
3
Working Capital Days
24
16
27
8
-3
-8
-4
5
-1
-19
-6
-25
ROCE %
12%
9%
8%
7%
10%
14%
8%
17%
14%
15%
17%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Apollo Hospitals insights

64 extracted metrics + investor summaries across FY00–FY26.

Log in — free

Shareholding Pattern

Others2.05%Govt.0.23%FIIs41.50%Public4.48%DIIs23.72%Promot.28.02%As ofJun 2026
2.49% of promoter holding pledged as of Jun 2026

Documents

Frequently Asked Questions about Apollo Hospitals

What does Apollo Hospitals Enterprise Ltd do?
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremo...
Where is Apollo Hospitals Enterprise Ltd (APOLLOHOSP) listed?
Apollo Hospitals Enterprise Ltd trades as APOLLOHOSP on the NSE and under code 508869 on the BSE.
Which sector does Apollo Hospitals Enterprise Ltd belong to?
Apollo Hospitals Enterprise Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd has a market capitalisation of ₹1,26,883 Cr, which places it in the Large Cap band.
What is the PE ratio of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd trades at a PE ratio of 60.80, on earnings per share of ₹72.05, against a book value of ₹659.33 per share.
What is the 52-week high and low of Apollo Hospitals Enterprise Ltd?
Over the last 52 weeks Apollo Hospitals Enterprise Ltd has traded between ₹6,696.5 and ₹9,050.
Does Apollo Hospitals Enterprise Ltd pay dividends?
Apollo Hospitals Enterprise Ltd has a dividend yield of 0.22%.
What is the Return on Equity (ROE) of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd reported a return on equity of 20.08%. Its debt-to-equity ratio is 0.90.

Company Information

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Website apollohospitals.com
CEO Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS
Employees 42,497
Listed 1996-01-10
Face Value ₹ 5
Issued Size 14,37,84,657

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/APOLLOHOSP.md for Apollo Hospitals Enterprise Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List